Target intelligence / Profile preview

Shigella flexneri 3a O-antigen polysaccharide

Molecular classification
Polysaccharide, Bacterial antigen
01

Overview

The Shigella flexneri 3a O-antigen polysaccharide is a component of lipopolysaccharide (LPS) on the outer membrane of S. flexneri serotype 3a bacteria, consisting of a repeating tetrasaccharide unit of N-acetylglucosamine-rhamnose-rhamnose-rhamnose with modifications including O-acetylation (group 6 antigen via oac gene from Sf6 phage on rhamnose III), glucosyl group (group 7,8 antigens via gtr genes from SfX phage on first rhamnose), and additional structural variations that distinguish it from the basic serotype Y backbone[1][2][4][5][6][7][12][13][15]. Biosynthesis involves sequential sugar transfer to undecaprenyl pyrophosphate (UndPP) by transferases, flipping to the periplasm via RfbX, polymerization by Rfc (chain length regulated by WzzB and others), and ligation to lipid A core by Rfa/WaaL[1][3][4]. It confers serotype-specific immunity, enhances bacterial survival by antigenic variation (often via horizontal gene transfer from phages like Sf6, SfX), promotes T3SS function through compact glycosylation, stabilizes the outer membrane, and influences motility via IcsA masking in bimodal chain lengths (short S-type and very long VL-type)[1][2][3][4][7][13]. As a key immunogen, it is targeted in multivalent conjugate vaccines against shigellosis[5][15].

Other names
S. flexneri 3a O-polysaccharideS. flexneri 3a OAgS. flexneri type 3a O-antigen
02

Mechanism of action

Induction of serotype-specific adaptive immunity via O-antigen epitopes Antibody-mediated neutralization of bacterial invasion

03

Biological functions

Virulence factorOuter membrane protectionModulation of type three secretion system (T3SS)Immune evasion through serotype specificity
04

Disease associations

Infection
05

Interacting drugs

Shigella-tetravalent bioconjugates (includes S. flexneri 3a O-polysaccharide linked to protein carrier)

1 more in the full profile.

Beyond the preview

Go deeper on Shigella flexneri 3a O-antigen polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shigella flexneri 3a O-antigen polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call